218 related articles for article (PubMed ID: 15296859)
1. Multifaceted roles of cyclooxygenase-2 in lung cancer.
Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
3. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Liao Z; Milas L
Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 in lung cancer.
Dubinett SM; Sharma S; Huang M; Dohadwala M; Pold M; Mao JT
Prog Exp Tumor Res; 2003; 37():138-62. PubMed ID: 12795053
[No Abstract] [Full Text] [Related]
5. Cyclooxygenase as a target in lung cancer.
Brown JR; DuBois RN
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
[TBL] [Abstract][Full Text] [Related]
6. Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ
Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
Romano M; Claria J
FASEB J; 2003 Nov; 17(14):1986-95. PubMed ID: 14597668
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer.
Patel S; Chiplunkar S
Indian J Biochem Biophys; 2007 Dec; 44(6):419-28. PubMed ID: 18320840
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
10. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
Amir M; Agarwal HK
Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
Koga H
Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
14. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
Sanborn R; Blanke CD
Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
[TBL] [Abstract][Full Text] [Related]
16. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
[TBL] [Abstract][Full Text] [Related]
17. [COX and study of cancer therapy].
Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1147-51. PubMed ID: 15332534
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Tuynman JB; Peppelenbosch MP; Richel DJ
Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
[TBL] [Abstract][Full Text] [Related]
20. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
Cao Y; Prescott SM
J Cell Physiol; 2002 Mar; 190(3):279-86. PubMed ID: 11857443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
